COMMUNIQUÉS West-GlobeNewswire

-
Ultragenyx and Kyowa Kirin Announce Publication of Phase 2 Study Results Demonstrating that Crysvita® (burosumab) Improved Outcomes in Children with X-linked Hypophosphatemia in the New England Journal of Medicine
23/05/2018 -
Cytori Therapeutic’s common stock to begin trading on adjusted basis on May 24, following one-for-ten reverse split
23/05/2018 -
Amarin to Present at the Jefferies Global Healthcare Conference
23/05/2018 -
Retrophin Receives Workplace Excellence Award
23/05/2018 -
The Cooper Companies Announces Executive Management Changes
23/05/2018 -
Myriad Announces Seven New Payer Coverage Decisions for Prolaris®
23/05/2018 -
Tonix Pharmaceuticals to Present at the 2018 American Society of Clinical Psychopharmacology
23/05/2018 -
Thetis Pharmaceuticals Receives $1.9 Million Fast-Track NIH Grant to Advance Novel Inflammatory Bowel Disease Drug Pipeline Toward Clinical Investigation
23/05/2018 -
Integra LifeSciences to Present at Healthcare Conferences in June 2018
23/05/2018 -
Emerald Health Sciences Inc.
23/05/2018 -
Greystone health and rehabilitation centers awarded nursing care center accreditation from The Joint Commission
23/05/2018 -
Seeing Is Believing: A Gene Therapy First
23/05/2018 -
Altasciences Establishes Strategic Alliance with Altreos Research Partners
23/05/2018 -
Altasciences établit une alliance stratégique avec Altreos Research Partners
23/05/2018 -
CROSSJECT : CROSSJECT éligible au PEA-PME
23/05/2018 -
Certains donneurs du sud de l’Alberta concernés par un incident lié à la protection des renseignements personnels
23/05/2018 -
Insider's tradings
23/05/2018 -
Rockwell Medical CEO Issues Press Release
23/05/2018 -
Theratechnologies Announces Agreement With AIDS Drug Assistance Program (ADAP) for Trogarzo™ and EGRIFTA®
23/05/2018
Pages